What is Adalimumab
Adalimumab is a tumor necrosis factor alpha (TNF-alpha) blocker used to treat rheumatoid arthritis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, and ulcerative colitis. It is also used to treat plaque psoriasis in adults. Adalimumab is a monoclonal antibody that binds to TNF-alpha, preventing it from causing inflammation.
Adalimumab is administered by injection under the skin. It is available as a brand name drug called Humira.
Benefits of Adalimumab
and Its Uses.
adalimumab (Humira) is a prescription medication used to treat a variety of conditions, including rheumatoid arthritis, Crohn’s disease, and psoriasis. It is a tumor necrosis factor (TNF) blocker, which means it works by blocking TNF, a protein that is involved in causing inflammation.
adalimumab is administered by injection. It is available in both a pre-filled syringe and a pen-injector.
adalimumab comes in two formulations: adalimumab-atto (Humira-atto) and adalimumab-adbm (Humira-adbm). adalimumab-atto is an “original” formulation that is no longer available. adalimumab-adbm is a “preferred” formulation that is available in both pre-filled syringes and pens.
Adalimumab has several benefits:
1) It is a very effective medication
Side Effects and Dosage of Adalimumab
Adalimumab is a monoclonal antibody used to treat various autoimmune diseases. The drug is available as a subcutaneous injection in pre-filled syringes.
Adalimumab is used to treat the following conditions:
– Rheumatoid arthritis
– Psoriatic arthritis
– Ankylosing spondylitis
– Crohn’s disease
– Ulcerative colitis
The recommended dosage of adalimumab depends on the condition being treated.
– For rheumatoid arthritis, the recommended dosage is 40 mg administered every other week.
– For psoriatic arthritis, the recommended dosage is 20 mg administered every other week.
– For ankylosing spondylitis, the recommended dosage is 40 mg administered every other week.
– For Crohn’s disease, the recommended dosage is 40 mg administered every other week.
– For ulcerative colitis